Bioequivalence and Bioavailability Forum

Numerical Convolution joao.reis 2022-03-24 16:35
- Numerical Convolution Helmut 2022-03-24 16:50
- Numerical Convolution dshah 2022-03-24 17:10
- Numerical Convolution jag009 2022-03-24 21:03

EMA on ƒ2 bootstrapping Helmut 2022-03-16 14:06
- EMA on ƒ2 bootstrapping Rayhope 2022-03-28 14:24
- EMA on ƒ2 bootstrapping khageswara Rao 2022-03-30 12:00

Batch selection based on CDP BE-proff 2022-02-24 06:25
- Batch selection based on CDP dshah 2022-03-02 19:17

dissolution, passing f2 but failing f1 Ahikal 2021-12-24 17:41
- dissolution, passing f2 but failing f1 dshah 2021-12-29 10:28

Prolonged release drug Farmacevt 2021-07-30 17:31
- MR: Different shapes Helmut 2021-08-05 13:43

IV Infusion/Bolus Pk normalisation pharm07 2021-06-22 11:09
- IV Infusion/Bolus Pk normalisation drgunasakaran1 2021-06-24 06:07
- IV Infusion/Bolus Pk normalisation msmnainar 2021-06-24 07:11
  - IV Infusion/Bolus Pk normalisation pharm07 2021-06-24 07:48
    - IV Infusion/Bolus Pk normalisation msmnainar 2021-06-24 19:04
      - IV Infusion/Bolus Pk normalisation pharm07 2021-06-25 04:51

IVIVC in R Tutorials Taonga Pomerai 2021-01-04 14:46

Dextromethorphan begoña 2020-10-08 12:14
- Dextromethorphan Sridhar.E 2020-10-08 12:27
  - Dextromethorphan begoña 2020-10-08 12:35
    - Dextromethorphan Sridhar.E 2020-10-08 12:59
- Dextromethorphan: Class II? Helmut 2020-10-08 12:54

Biowaiver for lower strength using different OGD media dshah 2020-07-13 08:09
- EMA: No biowaivers for NTIDs Helmut 2020-07-15 19:08
  - EMA: No biowaivers for NTIDs Relaxation 2020-07-16 10:54
    - Biowaiver only for BCS I and – under certain conditions – BCS III drugs Helmut 2020-07-16 11:27
      - Biowaiver only for BCS I and – under certain conditions – BCS III drugs Obinoscopy 2020-07-16 14:36
        
        Biowaiver only for BCS I and – under certain conditions – BCS III drugs dshah 2020-07-17 06:27
        
        Additional Strength Biowaiver Requirements Obinoscopy 2020-07-18 03:13
        Additional strength Biowaiver wienui 2020-07-18 18:00

Weibull method for Dissolution Similarlies Jainee 2020-04-30 18:10
- Weibull method for Dissolution Similarlies yjlee168 2020-04-30 18:31
  - Weibull method for Dissolution Similarlies Nirali 2020-05-01 07:37
- Weibull method for Dissolution Similarlies Achievwin 2020-05-07 03:49
  - Weibull method for Dissolution Similarlies Jainee 2020-05-10 11:35

Comp in-vitro disso studies for generics in India jag009 2020-03-12 15:41
- Comp in-vitro disso studies for generics in India ping4santosh 2020-03-12 19:18
  - Comp in-vitro disso studies for generics in India jag009 2020-03-13 17:34
    - Comp in-vitro disso studies for generics in India ping4santosh 2020-03-14 23:20
      - Comp in-vitro disso studies for generics in India jag009 2020-03-15 07:25
        
        Comp in-vitro disso studies for generics in India ping4santosh 2020-03-15 10:05

Glycopyrrolate BCS Class AB661 2020-01-29 10:12
- Glycopyrrolate BCS Class Achievwin 2020-02-04 23:17

Bio-waiver of Sapropterin dihydrochloride powder for oral solution AB661 2019-11-22 17:49
- Please do your homework first Helmut 2019-11-24 10:51
- Bio-waiver of Sapropterin dihydrochloride powder for oral solution Achievwin 2019-12-03 17:06

Dissolution Testing Requirement - ANDA jag009 2019-10-30 02:29

If method doesn't exist in FDA Disso Database jag009 2019-10-24 20:54
- USP should be fine Helmut 2019-10-25 00:33
  - USP should be fine jag009 2019-10-30 02:23

Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 9 (0 registered, 9 guests [including 3 identified bots]).
Forum time: Sunday 07:08 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top. Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz